Summary
Federal funding priorities are evolving, and companies have decisions to make about where to focus their time, resources, and partnerships.
EverGlade and QNova LifeSciences discussed the opportunities taking shape across federal agencies, regulatory considerations for development, and how to build a funding strategy around your company’s technical, financial, and commercial goals. Request the slides for a closer look at the discussion.
Date: September 24, 2026
Hosted by: EverGlade and QNova LifeSciences
Meet the Panelists
Laura Powell, PhD, PMP, Director, Technical Team Lead, EverGlade
Tyler Kessler, Director, Finance Team Lead, EverGlade
- Stephen Richardson, Head of Strategic Partnerships, EverGlade
Jim Sergi, President and Founder, QNova LifeSciences
Topics We Covered
Federal agency activity and opportunities heading into FY2027
Consortia, accelerator hubs, teaming, and early program-manager engagement
Civilian and military applications for life sciences technologies
FDA engagement and regulatory considerations that affect scope, cost, and timelines
Using federal awards to address development gaps and support longer-term financing
Preparing realistic budgets, development plans, and execution commitments before pursuing an award
Request the Webinar Slides
Complete the form to receive a copy of the presentation from The FY2027 Federal Funding Strategy Playbook webinar.
You can also request a consultation with EverGlade to discuss agency fit, development priorities, and where federal funding could support your company’s plans.
Join Our Quarterly Webinars
EverGlade’s quarterly webinars bring together perspectives on federal funding, technical development, regulatory planning, and program execution.
Stay connected for upcoming topics, guest speakers, and registration announcements.
